Isaiah Davis

Isaiah Davis currently serves as a Director at Merck, starting in July 2024, and has been an Associate at Mass Medical Angels since July 2017, where responsibilities include liaising between Novartis and third-party medical technology providers and assisting with due diligence. Prior experience includes roles as Associate Director at Vertex Pharmaceuticals and Novartis Institutes for BioMedical Research (NIBR), where Isaiah Davis facilitated alliances and managed collaborations to advance research and development. Early career positions included Scientist I and Associate Scientist II at various prestigious institutions, contributing to efficiency and cost savings in laboratory operations. Isaiah Davis holds an MBA in Health Care Administration and Management from Boston University and a BS in Biology from Providence College.